Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MSTR vs MRNA✓SelectedUSD · MRNAMSTR vs MRNA performance historyLatest closeAs of-4.64%11/19
Stock and ETF performance explorer

MSTR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+69.4%
MRNA return
+159.5%
Excess return
-90.2%
Maximum drawdown
-82.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.6%+1.3%-5.9%-4.8%
7D-24.7%-13.8%-10.9%-23.2%
30D-39.7%-17.7%-22.0%-38.2%
3M-17.4%+14.3%-31.7%-19.6%
6M-47.7%+336.0%-383.7%-62.9%
YTD-43.3%+575.9%-619.2%-64.2%
1Y-53.8%+724.4%-778.2%-72.4%
All+69.4%+159.5%-90.2%+45.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling